Synthesizing Mind-Sets for Participants Undergoing Clinical Trials — The Case of Weight Loss Drugs

Abstract

The paper focuses on the synthesis of mind-sets for patients who are undergoing clinical trials with weight-reducing drugs. The objective is to demonstrate how LLMs, large language models, can be combined with Mind Genomics thinking to better understand how patients in these clinical trials may think. Although the data are simulated, the outcome provides a way for the clinician and the drug manufacturer, as well as the participating physician, to understand the deeper thoughts of the study participants. As such, the approach is presented as a didactic tool to introduce the minds of patients as people to clinicians and to drug companies, doing so in the same spirit as consumer researchers seek to understand the corporation’s customers.